Abstract
Previously, recurrence of insulin-dependent diabetes mellitus after pancreas transplants was only sporadically reported. Newer data, however, indicate recurrence rates as high as 5%. After identical-twin pancreas transplants, diabetes recurs in the absence of immunosuppressive therapy - strong evidence that it is an autoimmune disease. After deceased donor pancreas transplants, immunologic markers (autoantibodies, autoreactive T cells) herald recurrence. Selective destruction of β cells, still relatively uncommon, is not restricted to MHC compatibility. The development of diabetes in living pancreas donors is rare; it can be largely avoided by meticulous metabolic evaluation before donation and prevention of obesity after donation.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 543-551 |
| Number of pages | 9 |
| Journal | Expert Review of Clinical Immunology |
| Volume | 7 |
| Issue number | 4 |
| DOIs | |
| State | Published - Jul 2011 |
Keywords
- GAD-65
- IA-2
- diabetes mellitus
- islet cells
- living donor
- pancreas transplant
- post-transplant recurrence
- twin
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
Fingerprint
Dive into the research topics of 'Development of diabetes mellitus in living pancreas donors and recipients'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS